Hemlibra Injection, Solution
Product Images NDC 50242-920

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 47 technical images submitted to the FDA as part of the official labeling for Hemlibra (NDC 50242-920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Hemlibra 01)

Figure (Hemlibra 01)
This text describes a Transfer Needle with Filter that is used specifically for transferring the medication HEMLIBRA from a vial to a syringe. The product consists of a needle and cap with an enclosed filter.*
FDA Label Image

Figure (Hemlibra 02)

Figure (Hemlibra 02)
FDA Label Image

Figure (Hemlibra 03)

Figure (Hemlibra 03)
FDA Label Image

Figure (Hemlibra 04)

Figure (Hemlibra 04)
FDA Label Image

Figure (Hemlibra 05)

Figure (Hemlibra 05)
FDA Label Image

Figure (Hemlibra 06)

Figure (Hemlibra 06)
This is not enough information to generate a useful description. The text seems to be labels for parts or products, but there is no context or further information available.*
FDA Label Image

Figure (Hemlibra 07)

Figure (Hemlibra 07)
This is a description of a needle with a safety shield and cap.*
FDA Label Image

Figure (Hemlibra 08)

Figure (Hemlibra 08)
FDA Label Image

Figure (Hemlibra 09)

Figure (Hemlibra 09)
FDA Label Image

Figure (Hemlibra 10)

Figure (Hemlibra 10)
Upper arm is a body part located between the shoulder and elbow joints. It is made up of bone, muscle, and connective tissue, and is responsible for providing strength and mobility to the shoulder and elbow joints.*
FDA Label Image

Figure (Hemlibra 11)

Figure (Hemlibra 11)
FDA Label Image

Figure (Hemlibra 12)

Figure (Hemlibra 12)
FDA Label Image

Figure (Hemlibra 13)

Figure (Hemlibra 13)
FDA Label Image

Figure (Hemlibra 14)

Figure (Hemlibra 14)
FDA Label Image

Figure (Hemlibra 15)

Figure (Hemlibra 15)
FDA Label Image

Figure (Hemlibra 16)

Figure (Hemlibra 16)
FDA Label Image

Figure (Hemlibra 17)

Figure (Hemlibra 17)
FDA Label Image

Figure (Hemlibra 18)

Figure (Hemlibra 18)
FDA Label Image

Figure (Hemlibra 19)

Figure (Hemlibra 19)
FDA Label Image

Figure (Hemlibra 20)

Figure (Hemlibra 20)
FDA Label Image

Figure (Hemlibra 21)

Figure (Hemlibra 21)
FDA Label Image

Figure (Hemlibra 22)

Figure (Hemlibra 22)
FDA Label Image

Figure (Hemlibra 23)

Figure (Hemlibra 23)
FDA Label Image

Figure (Hemlibra 24)

Figure (Hemlibra 24)
FDA Label Image

Figure (Hemlibra 25)

Figure (Hemlibra 25)
FDA Label Image

Figure (Hemlibra 26)

Figure (Hemlibra 26)
FDA Label Image

Figure (Hemlibra 27)

Figure (Hemlibra 27)
FDA Label Image

Figure (Hemlibra 28)

Figure (Hemlibra 28)
FDA Label Image

Figure (Hemlibra 29)

Figure (Hemlibra 29)
FDA Label Image

Figure (Hemlibra 30)

Figure (Hemlibra 30)
FDA Label Image

Figure (Hemlibra 31)

Figure (Hemlibra 31)
FDA Label Image

Figure (Hemlibra 32)

Figure (Hemlibra 32)
FDA Label Image

Figure (Hemlibra 33)

Figure (Hemlibra 33)
FDA Label Image

Figure (Hemlibra 34)

Figure (Hemlibra 34)
FDA Label Image

Figure (Hemlibra 35)

Figure (Hemlibra 35)
FDA Label Image

Figure (Hemlibra 36)

Figure (Hemlibra 36)
FDA Label Image

Figure (Hemlibra 37)

Figure (Hemlibra 37)
FDA Label Image

Figure (Hemlibra 38)

Figure (Hemlibra 38)
FDA Label Image

Figure (Hemlibra 39)

Figure (Hemlibra 39)
FDA Label Image

Figure (Hemlibra 40)

Figure (Hemlibra 40)
FDA Label Image

Figure (Hemlibra 41)

Figure (Hemlibra 41)
FDA Label Image

Hemlibra 41a

Hemlibra 41a
FDA Label Image

Hemlibra 41b

Hemlibra 41b
FDA Label Image

Principal Display Panel (30 mg Vial Carton)

Principal Display Panel (30 mg Vial Carton)
Hemlibra® is a medication that can be injected subcutaneously using a single-dose vial. Each vial contains 30 mg/mL of emicizumab-kxwh. It is important to discard any unused portions after administration. The medication guide enclosed should be dispensed to each patient. The NDC number for the medication is 50242-920-01 and it is manufactured by Genentech.*
FDA Label Image

Principal Display Panel (60 mg Vial Carton)

Principal Display Panel (60 mg Vial Carton)
Hemlibra is a medication for subcutaneous use that comes in a single-dose vial containing 60mg/0.4mL of emicizumab-kxwh. The product should be discarded if any remaining quantity is leftover. The enclosed medication guide should be given to each patient.*
FDA Label Image

Principal Display Panel (105 mg Vial Carton)

Principal Display Panel (105 mg Vial Carton)
Hemlibra is a medication available in a single-dose vial for subcutaneous injection. It contains emicizumab-kxwh and is used to treat hemophilia. A medication guide should be included and unused portions should be discarded.*
FDA Label Image

Principal Display Panel (150 mg Vial Carton)

Principal Display Panel (150 mg Vial Carton)
Hemlibra is a medication used through subcutaneous injection. It comes in single-dose vials containing 150 mg/mL of emicizumab-kxwh. The medication guide enclosed with the product must be dispensed to each patient. This text appears to be a label for the medication, including the NDC number and product name.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.